Search
Last update: : 15.07.2025
We offer Olink Reveal™, a cost-effective, cutting-edge platform for high-throughput biomarker discovery and profiling, as a full service analysis. What is Olink Reveal™? Olink Reveal™ is…
Last update: : 15.07.2025
With its Proof of Concept grants, the European Research Council (ERC) supports scientists in further developing the economic potential of their research results. Two scientists from the German Cancer…
Press releaseLast update: : 10.07.2025
National Decade Against Cancer The strategic partnership is also a contribution by the DFKZ and the German Cancer Aid to the National Decade Against Cancer, which the Federal Ministry of Education…
Last update: : 09.07.2025
Fortunately, survival rates for most cancers have improved significantly over the last few decades. It is estimated that there are currently around five million cancer survivors in Germany (persons…
Last update: : 09.07.2025
The goal of the Central Virus Transduction Service is to provide fast, cost-effective and uncomplicated access to virus transduced cell lines. The Virus Transduction Service offers the packaging…
Last update: : 09.07.2025
The stable isogenic cell line service provides highly standardized cell line models for functional analysis and high throughput screening. By integration of a specific recombination site in our…
Last update: : 09.07.2025
Cancer does not develop overnight. It can take decades for cancer-promoting changes in the genome to eventually lead to the formation of a malignant tumor. Researchers at the German Cancer Research…
Press releaseLast update: : 08.07.2025
Please note that the Open Access components contractually negotiated with the publishers are very complex. Whether discounts are granted on the Article Processing Charges (APCs) or no costs are…
Last update: : 08.07.2025
GPOH-Zentren, die diese Vertrag-Ergänzung bereits unterzeichnet haben: 1. Uniklinik RWTH Aachen (Klinik für Kinder-u. Jugendmedizin) 2. Universitätsklinikum Augsburg AöR (Klinik für Kinder und…
Document